MEIS2 and breast cancer: We analyzed the Kaplan–Meier (KM) overall survival curves for the MEIS2 expression in two datasets of BC,31 and found that the OS time of patients with high expression of MEIS2 was significantly longer than that with low expression (Figure 2C,D).